{"id":"NCT01954056","sponsor":"NICHD Neonatal Research Network","briefTitle":"Hydrocortisone for Term Hypotension","officialTitle":"Hydrocortisone Treatment of Cardiovascular Insufficiency in Term and Late Preterm Infants: A Randomized Controlled Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-19","primaryCompletion":"2018-03-20","completion":"2018-03-20","firstPosted":"2013-10-01","resultsPosted":"2019-04-02","lastUpdate":"2021-07-06"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Infant, Newborn, Diseases","Cardiovascular Insufficiency"],"interventions":[{"type":"DRUG","name":"Hydrocortisone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Hydrocortisone","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial will evaluate the effects of a 7-day course of hydrocortisone therapy on short-term morbidity, cardiovascular function, long-term neurodevelopment, and mortality in critically ill, term and late preterm infants diagnosed with cardiovascular insufficiency as defined by a need for inotrope therapy in the first 72 hours of age.","primaryOutcome":{"measure":"Death","timeFrame":"Birth to 22-26 months corrected gestational age","effectByArm":[{"arm":"Hydrocortisone","deltaMin":6,"sd":null},{"arm":"Placebo","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"34 Weeks","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":13},"locations":{"siteCount":18,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://neonatal.rti.org/","http://www.nichd.nih.gov/about/org/der/branches/ppb/Pages/overview.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":6},"commonTop":["ATRIAL TACHYCARDIA"]}}